Loading…
Anbio Biotechnology is projected to decline to $10.34 by 2027, a -7% move from its current price of $11.15. NNNN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $10.47 | $11.16 | $11.90 | +0.11% |
| Jul 14 | $10.21 | $11.18 | $12.23 | +0.23% |
| Jul 15 | $10.02 | $11.19 | $12.49 | +0.34% |
| Jul 16 | $9.86 | $11.20 | $12.72 | +0.46% |
| Jul 17 | $9.72 | $11.21 | $12.93 | +0.57% |
| Jul 18 | $9.60 | $11.23 | $13.12 | +0.69% |
| Jul 19 | $9.50 | $11.24 | $13.30 | +0.80% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.50 | $11.24 | $13.30 | +0.80% |
| Week 2 | $8.93 | $11.33 | $14.38 | +1.61% |
| Week 3 | $8.53 | $11.42 | $15.29 | +2.43% |
| Week 4 | $8.22 | $11.51 | $16.13 | +3.26% |
| Week 5 | $7.96 | $11.61 | $16.92 | +4.09% |
| Week 6 | $7.74 | $11.70 | $17.68 | +4.92% |
| Week 7 | $7.55 | $11.79 | $18.42 | +5.77% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits. It serves over-the-counter, point-of-care testing, and laboratory markets.
Anbio Biotechnology was incorporated in 2021 and is based in Frankfurt am Main, Germany.
Anbio Biotechnology (NNNN) operates in the Healthcare sector as an in vitro diagnostics provider with global reach. The stock is currently priced at $11.15 and has a market capitalization of $489.39M, ranking 3077 by market cap. The current setup places the asset among healthcare names with a global product footprint and a diversified testing portfolio.
A major floor 15.8% below — a decisive break under it would weaken the trend.
The nearest floor, 15.8% below — buyers have tended to step in here.
The nearest ceiling, 208.9% above — a clean break opens room to run.
A major ceiling 283.8% above — clearing it would confirm fresh momentum.
Key NNNN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NNNN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.15 | Sell | $11.02 | Buy |
| MA 10 | $12.26 | Sell | $12.26 | Sell |
| MA 20 | $14.18 | Sell | $14.75 | Sell |
| MA 50 | $22.29 | Sell | $19.62 | Sell |
| MA 100 | $23.61 | Sell | $22.75 | Sell |
| MA 200 | $25.98 | Sell | $24.34 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 21.99 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -163.37 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | -40.19 | Sell |
| Bollinger %B (20,2) | -0.05 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -2.38 | Sell |
| Awesome (5,34) | -8.60 | Sell |
| Ultimate (7,14,28) | 10.15 | Buy |
| Momentum (10) | -6.71 | Sell |
| Aroon Osc (25) | -100.00 | Sell |
| Hull MA (9) | 10.34 | Buy |
| ADX (14) | 39.84 | Sell |
| ATR (14) | 0.95 | Info |
In the near term, sentiment is NEUTRAL with a RSI14 of 30. The 50-day simple moving average is $22.66 and the 200-day simple moving average is $26.12, implying a pullback potential toward the near-term price levels. The stock shows a defined support at $11.15 and resistance at $34.44, framing the upside versus downside risk.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.39 | $11.15 | $17.00 | 0% | Neutral | |
| $7.43 | $10.34 | $15.57 | -7% | Neutral | |
| $7.59 | $11.26 | $18.11 | +1% | Neutral | |
| $7.08 | $11.09 | $18.76 | 0% | Neutral | |
| $6.00 | $9.90 | $17.45 | -11% | Neutral | |
| $8.65 | $14.95 | $27.30 | +34% | Bullish | |
| $9.43 | $17.05 | $32.14 | +53% | Bullish | |
| $8.47 | $16.01 | $31.03 | +44% | Bullish | |
| $8.00 | $15.77 | $31.37 | +41% | Bullish | |
| $6.74 | $13.85 | $28.20 | +24% | Bullish | |
| $10.15 | $22.56 | $50.60 | +102% | Bullish | |
| $20.13 | $44.73 | $102.87 | +301% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $9.39 | $11.15 | $14.23 | +0.00% |
| August 2026 | $10.27 | $12.47 | $15.81 | +11.88% |
| September 2026 | $10.04 | $12.38 | $16.02 | -0.79% |
| October 2026 | $9.58 | $11.97 | $15.77 | -3.31% |
| November 2026 | $9.78 | $12.35 | $16.52 | +3.20% |
| December 2026 | $9.83 | $12.53 | $17.00 | +1.47% |
Click any year to see its month-by-month NNNN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The NNNN price prediction for 2026 points to an average of $11.15 (low $9.39, high $17.00) — a potential gain of 0% on today's $11.15. A consolidation phase looks the most probable path here.
In 2027, NNNN is projected to trade between $7.43 and $15.57, averaging $10.34 — a potential decline of -7% from today's $11.15. That is -7% versus the projected 2026 average. Price action looks broadly range-bound.
Anbio Biotechnology's 2028 outlook centres on $11.26, within a $7.59 to $18.11 range. That is up +9% on the projected 2027 average. That marks a +1% change versus current levels. A consolidation phase looks the most probable path here.
By 2029, NNNN could reach as high as $18.76, with a base case around $11.09 and support toward $7.08 — roughly 0% from $11.15. Price action looks broadly range-bound.
Expect NNNN to range from $6.00 to $17.45 through 2030. The $9.90 average target implies a -11% move from current prices. That is -11% versus the projected 2029 average. A consolidation phase looks the most probable path here.
The NNNN price prediction for 2031 points to an average of $14.95 (low $8.65, high $27.30) — a potential gain of +34% on today's $11.15. Momentum favours further upside here.
In 2032, NNNN is projected to trade between $9.43 and $32.14, averaging $17.05 — a potential gain of +53% from today's $11.15. That is up +14% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Anbio Biotechnology's 2033 outlook centres on $16.01, within a $8.47 to $31.03 range. That is -6% versus the projected 2032 average. That marks a +44% change versus current levels. Momentum favours further upside here.
By 2034, NNNN could reach as high as $31.37, with a base case around $15.77 and support toward $8.00 — roughly +41% from $11.15. Buyers look set to stay in control over this stretch.
Expect NNNN to range from $6.74 to $28.20 through 2035. The $13.85 average target implies a +24% move from current prices. That is -12% versus the projected 2034 average. Momentum favours further upside here.
The NNNN price prediction for 2040 points to an average of $22.56 (low $10.15, high $50.60) — a potential gain of +102% on today's $11.15. Buyers look set to stay in control over this stretch.
In 2050, NNNN is projected to trade between $20.13 and $102.87, averaging $44.73 — a potential gain of +301% from today's $11.15. That is up +98% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in NNNN today (≈ 89.686099 NNNN) could be worth
$4,011.26
+$3,011.26 (+301%) by 2050 · US Dollar
Based on the average projected NNNN price of $44.73 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NNNNwould be worth at today's price.
$1,000 invested in NNNN on Jul 10, 2025 (≈ 19.710259 NNNN) would be worth
$219.77
-$780.23 (-78.0%) today · 0.22× · US Dollar
Based on a NNNN entry price of $50.74 vs. today's $11.15.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $12.7 | $877.95 | -12.2% |
| 1 month ago | $16.43 | $678.64 | -32.1% |
| 3 months ago | $27.1 | $411.44 | -58.9% |
| 6 months ago | $35.69 | $312.41 | -68.8% |
| 1 year ago | $50.74 | $219.77 | -78.0% |
| All time (1.4y) ago | $5.77 | $1,932.41 | +93.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NNNN forecast.
Our base-case forecast reaches $22.00 around 2040.
Implied market cap at $22.00: $965.61M
The multi-year forecast shows a path from a flat start in 2026 (min $11.15, avg $11.15, max $16.98; ROI 0) to meaningful upside in later years. Notably, 2031–2035 transition to bullish sentiment, with 2031 avg $15.96 and ROI 43.1%, 2032 avg $17.93 and ROI 60.8%, 2033 avg $16.84 and ROI 51%, 2034 avg $16.75 and ROI 50.2%, and 2035 avg $14.84 and ROI 33.1%. The forecast then accelerates into 2040 with avg $24.45 and ROI 119.3% (min $11.00, max $54.93), and culminates in 2050 with avg $50.01 and ROI 348.5% (min $22.50, max $115.02).
These figures point to bullish momentum in the long run, but the outlook includes years with neutral or modest moves and acknowledges that estimates are not guarantees and actual results may vary.
Tap a question to reveal the answer.
2030 — min $6.42, avg $10.60, max $18.70; ROI -5%; sentiment NEUTRAL.
Forecasts show a mix of neutral and bullish years. 2026 is neutral with 0% ROI, 2027 shows a negative ROI (-6.3%), and 2028–2035 display positive returns, culminating in strong bullish potential in 2040 (ROI 119.3%) and 2050 (ROI 348.5%). These are estimates and not guarantees.
Yes. The 2040 forecast max price is $54.93, with a mid-range average of $24.45 and a bullish sentiment.
Current price: $11.15. Market cap: $489.39M.
2050 max price is $115.02, with an average of $50.01 and a bullish sentiment.
Anbio Biotechnology Community Discussion
0Share your Anbio Biotechnology price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.